Thrivent Financial for Lutherans’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-72,429
| Closed | -$275K | – | 2327 |
|
|
2020
Q1 | $275K | Buy |
72,429
+3,616
| +5% | +$13.7K | ﹤0.01% | 2020 |
|
|
2019
Q4 | $350K | Buy |
68,813
+911
| +1% | +$4.63K | ﹤0.01% | 2017 |
|
|
2019
Q3 | $343K | Buy |
67,902
+1,576
| +2% | +$7.96K | ﹤0.01% | 1990 |
|
|
2019
Q2 | $409K | Buy |
66,326
+1,838
| +3% | +$11.3K | ﹤0.01% | 1923 |
|
|
2019
Q1 | $299K | Buy |
64,488
+5,119
| +9% | +$23.7K | ﹤0.01% | 2003 |
|
|
2018
Q4 | $249K | Buy |
59,369
+1,305
| +2% | +$5.47K | ﹤0.01% | 1869 |
|
|
2018
Q3 | $364K | Buy |
58,064
+7,493
| +15% | +$47K | ﹤0.01% | 1816 |
|
|
2018
Q2 | $407K | Buy |
50,571
+4,599
| +10% | +$37K | ﹤0.01% | 1789 |
|
|
2018
Q1 | $343K | Buy |
45,972
+2,709
| +6% | +$20.2K | ﹤0.01% | 1815 |
|
|
2017
Q4 | $257K | Buy |
43,263
+853
| +2% | +$5.07K | ﹤0.01% | 1931 |
|
|
2017
Q3 | $312K | Buy |
42,410
+30
| +0.1% | +$221 | ﹤0.01% | 1774 |
|
|
2017
Q2 | $288K | Buy |
42,380
+2,710
| +7% | +$18.4K | ﹤0.01% | 1766 |
|
|
2017
Q1 | $374K | Buy |
+39,670
| New | +$374K | ﹤0.01% | 1666 |
|
|
2016
Q2 | – | Sell |
-103,280
| Closed | -$450K | – | 2051 |
|
|
2016
Q1 | $450K | Hold |
103,280
| – | – | ﹤0.01% | 1414 |
|
|
2015
Q4 | $633K | Buy |
+103,280
| New | +$633K | ﹤0.01% | 1242 |
|